Farr Laboratories

In 1999, Farr Laboratories, in collaboration with leading academic urologists at the Institute of Male Urology (Triurol, Inc.), began developing a safe, effective, and natural approach to address symptoms associated with sterile chronic prostatitis (Category III Prostatitis), also known as Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS). Farr Laboratories, LLC is committed to ensuring that the company’s product formulations evolve in line with the latest clinical research and recommendations from its Medical Advisory Board.